Yuejun Du
Impact in
-
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Renal cell carcinoma treatment
-
- Cancer-related molecular mechanisms research
Papers in
-
- Renal cell carcinoma treatment 5
- Chronic Obstructive Pulmonary Disease (COPD) Research 5
- Respiratory Support and Mechanisms 2
-
- RNA Research and Splicing 3
- Ubiquitin and proteasome pathways 2
- Co-authors
- Zhibo Xu (4 shared papers)Wanlong Tan (5 shared papers)Lina Hou (6 shared papers)Mingjin Yang (3 shared papers)Hong Chen (5 shared papers)Wanlong Tan (3 shared papers)Pengliang Chen (2 shared papers)Chenyun He (1 shared paper)
In The Last Decade
Yuejun Du
25 papers receiving 448 citations
Peers
Comparison fields: 5 of 57
- Pulmonary and Respiratory Medicine 162
- Cancer Research 60
- Surgery 94
- Oncology 45
- Issues, ethics and legal aspects 2
Countries citing papers authored by Yuejun Du
This map shows the geographic impact of Yuejun Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuejun Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuejun Du more than expected).
Fields of papers citing papers by Yuejun Du
This network shows the impact of papers produced by Yuejun Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuejun Du. The network helps show where Yuejun Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Yuejun Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 54 | |
| 2 | The increased excretion of urinary orosomucoid 1 as a useful biomarker for bladder cancer. | 2016 | 51 |
| 3 | 2019 | 40 | |
| 4 | 2019 | 38 | |
| 5 | 2017 | 32 | |
| 6 | 2013 | 31 | |
| 7 | 2016 | 25 | |
| 8 | 2016 | 24 | |
| 9 | 2016 | 21 | |
| 10 | 2009 | 20 | |
| 11 | 2013 | 19 | |
| 12 | 2021 | 18 | |
| 13 | 2015 | 17 | |
| 14 | 2016 | 12 | |
| 15 | 2020 | 10 | |
| 16 | 2017 | 10 | |
| 17 | [Relationship between programmed cell death 5 protein expression and prognosis of renal clear cell carcinoma]. | 2006 | 6 |
| 18 | 2022 | 5 | |
| 19 | 2021 | 4 | |
| 20 | 2024 | 3 |
About Yuejun Du
Yuejun Du is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Surgery, Physiology and Cancer Research, having authored 27 papers that have together received 449 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (5 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers), Bladder and Urothelial Cancer Treatments (4 papers), RNA Research and Splicing (3 papers), Urinary and Genital Oncology Studies (3 papers), Asthma and respiratory diseases (3 papers), Ubiquitin and proteasome pathways (2 papers) and Respiratory Support and Mechanisms (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (162 citations), Cancer Research (60 citations), Surgery (94 citations), Oncology (45 citations) and Issues, ethics and legal aspects (2 citations). Yuejun Du has collaborated with scholars based in China, Germany and Finland. Frequent co-authors include Zhibo Xu, Wanlong Tan, Lina Hou, Mingjin Yang, Hong Chen, Wanlong Tan, Pengliang Chen, Chenyun He, Boris Hadaschik and Hong Chen. Their work appears in journals such as BMC Pulmonary Medicine, International Immunopharmacology, Oncotarget, Advanced Science and Clinical Genitourinary Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.